Nordic Precision Medicine Forum Agenda
20-21 March 2018, Copenhagen

20th March:


Registration and welcome coffee


Nationwide Precision Medicine Initiatives; an update on current plans and where we are heading

Gert Sorensen, Director, Danish National Genome Centre

Aarno Palotie, Research Director, FIMM

Richard Rosenquist Brandell, Professor of Clinical Genetics Department of Molecular Medicine and Surgery, Karolinska Institutet and Senior Physician in Clinical Genetics at Karolinska University Hospital. Project Leader, Genomics Medicine Sweden

Dr. Jaakko Yrjö-Koskinen, Special Advisor, Health Affairs, Department of Social and Health Services Ministerial Counsellor

Anne Hafstad, Project Director, Personalised Medicine, Norwegian Health Directorate

A series of presentations outlining precision medicine based initiatives across the Nordics. Discover the latest progress and what the future holds for precision medicine. From the latest about genomics centres to biobanking and data sharing. Followed by a panel session allowing more in-depth discussions.


Networking coffee


The Patient Perspective

In 2017 Lars Werner was appointed member of the Board responsible for Implementing the National Strategy for Precision Medicine in Denmark by “Danske Patienter” (Danish Patients), an umbrella organisation for a number of patient organisations in Denmark. This presentation will discuss patient centric precision medicine and how patient groups are working together with all other stakeholders to help devise the best route to precision medicine across Denmark:

Lars Werner, Director, Psoriasisforeningen

The Ethics of personalised Medicine:

Prof. Mette Nordahl Svendsen, Department of Public Health Centre for Medical Science and Technology Studies, University of Copenhagen


How Biomarker Development and Diagnostics are key to precision medicine

The need for thinking in composite biomarkers and to ensure we have freedom to operate with the purpose of epidemiological investigations to understand the underlying disease biology. This will lead to new disease classes  - a discussion of how to validate diagnoses will be needed.

Birgitte Sogaard, Divisional Director Clinical & Quantitative Pharmacology, H. Lundbeck A/S

Investigating the opportunities for establishing a biomarker development infrastructure in Denmark. Kim will discuss his efforts within a Government funded project focusing on evaluating the development of biomarkers as an emerging growth area in Denmark.

Kim Holmstrøm, R&D Manager Molecular Detection, Bioneer A/S

Estrid Høgdall, Clinical professor in Molecular Pathology at University of Copenhagen and Head of Molecular Unit, Department of Pathology


Complimentary Networking Dinner and Drinks Reception

21st March:


Welcome Coffee


Welcome introduction from your Chair:

Vivienne Parry OBE, Head of Engagement at Genomics England

A scientist by training, Vivienne hosts medical programmes for Radio 4, writes widely on health, presents films, facilitates many high level conferences and debates and trains young researchers.  She also has a part time role as head of engagement at Genomics England which is delivering the 100,000 Genomes Project.  In September 2017 she was appointed to the board of UK Research & Innovation.


Interview session with Precision Medicine thought leaders:

This unique session sees an open discussion allowing for a vibrant discussion of the most pressing issues facing us in the implementation of precision medicine. Including a diverse range of topics from the convergence of multi-omics to lifestyle, cross border collaboration and overcoming challenges such as regulatory hurdles.

Professor Olli Kallioniemi, Director, SciLifeLab at Karolinska Institutet

Paul W Franks Professor and Deputy Director of Lund University Diabetes Center in Sweden, Head of Genetic & Molecular Epidemiology Unit

Morten Sogaard, Ph.D, Vice President & Global Head,  WRD Genome Sciences & Technologies Pfizer


Clinical Implementation of Precision Medicine

Precision medicine can radically improve health care within the next decade

  • How Precision Medicine can reduce the use and cost of ineffective drugs
  • New technical solutions to bridge the gap between DNA and diagnosis
  • Single cell analysis
  • Practical solutions for clinical translation

Mikael Benson, MD, Professor, The Center for Personalised Medicine, Linköping University Hospital

Ulrik Lassen, Head of Unit Oncology, Rigshospitalet

Overview of Norwegian clinical trial (MetAction study) where we have looked for a defined set of actionable targets in metastatic solid tumors (by sequencing) and leveraged treatment on an individual basis:

Gunhild M. Mælandsmo, Prof, PhD, Head, Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital


Networking Coffee Break


Data, Data Everywhere- How do we best standardize, regulate and utilize the enormous amount of data we have?

The Role of Real World Evidence Data in Regulatory and Clinical Practice Settings going forward. The special role of The Nordics, given the great government databases in the region:

Danilo Verge,  Vice President for Cardiovascular and Metabolic Disease (CVMD) in Global Medical Affairs, Astrazeneca

Data-sharing; The Importance of Trust:

Jaana Sinipuro, Project Director, Sitra

Soren Brunak, Professor, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen


The Economics of Precision Medicine

With the cost of sequencing continuing to fall, how close are we to ubiquitous precision medicine and what is the associated economic impact on healthcare systems?


Networking Lunch


Roundtable sessions:

Designed to allow participants to deep-delve into specific topics, this session promotes open debate and helps formulate new strategies and partnerships.

Topics Covered include:

  • AI/Machine Learning
  • Big Data
  • Clinical implementation of precision medicine
  • Diagnostics for enabling precision medicine
  • Healthcare Economics
  • Next Generation Sequencing
  • Liquid Biopsy
  • Biomarker Development
  • Precision oncology
  • Multi-omics technologies
  • Biobanking


Networking Coffee Break


Multi-Omics Technologies

Prof Joakim Lundberg, Director of the Genomics Platform, Science for Life Laboratory KTH Division of Gene Technology


Focus on Disease areas

Whilst cancer leads the way precision medicine is high on the agenda for rare diseases, diabetes, cardio and more. Hear about the latest breakthroughs and progress that is being made across disease:

Cardiovascular Diseases:

Agneta Siegbahn, Platform Director of the Clinical Biomarkers Facility, SciLifeLab


Leif Groop, Director of Lund University Diabetes Centre


Speaker TBC


Closing Remarks
  • 00Days
  • 00Hours
  • 00Minutes

Share The News

“if we can convert even half of our leads into sales this will make it a massive success. Precision Medicine Forum Nordic is must for 2018”Olink Proteomics